Astrana Health (NASDAQ:ASTH) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Astrana Health (NASDAQ:ASTH) was given a new $37.00 price target on by analysts at Jefferies Financial Group Inc..
Astrana Health (NASDAQ:ASTH) was given a new $26.00 price target on by analysts at Barclays PLC.
A Look at Astrana Health's (ASTH) Valuation Following Earnings Miss and Lowered Guidance [Yahoo! Finance]
Astrana Health (NASDAQ:ASTH) was downgraded by analysts at
Weiss Ratings from a "hold (c-)" rating to a "sell (d+)" rating.